Warning: The NCBI web site requires JavaScript to function. more...
Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness.
Bogen K, Biener L, Garrett CA, Allen J, Cummings KM, Hartman A, Marcus S, McNeill A, O'Connor RJ, Parascandola M, Pederson L.
Harm Reduct J. 2009 Oct 19;6:27.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.
Parascandola M, Augustson E, O'Connell ME, Marcus S.
Nicotine Tob Res. 2009 Jul;11(7):886-95. Epub 2009 Jun 18.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Smoker and ex-smoker reactions to cigarettes claiming reduced risk.
Shiffman S, Pillitteri JL, Burton SL, Di Marino ME.
Tob Control. 2004 Mar;13(1):78-84.
Smoker awareness of and beliefs about supposedly less-harmful tobacco products.
O'Connor RJ, Hyland A, Giovino GA, Fong GT, Cummings KM.
Am J Prev Med. 2005 Aug;29(2):85-90.
Findings and implications from a national study on potential reduced exposure products (PREPs).
Hund LM, Farrelly MC, Allen JA, Chou RH, St Claire AW, Vallone DM, Healton CG.
Nicotine Tob Res. 2006 Dec;8(6):791-7.
New tobacco products: do smokers like them?
Caraballo RS, Pederson LL, Gupta N.
Tob Control. 2006 Feb;15(1):39-44.
Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.
O'Connor RJ, Cummings KM, Rees VW, Connolly GN, Norton KJ, Sweanor D, Parascandola M, Hatsukami DK, Shields PG.
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3334-48. Review.
Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products.
Biener L, Bogen K, Connolly G.
Tob Control. 2007 Oct;16(5):306-11.
Consumer awareness and attitudes related to new potential reduced-exposure tobacco products.
Parascandola M, Hurd AL, Augustson E.
Am J Health Behav. 2008 Jul-Aug;32(4):431-7.
Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications.
Pederson LL, Nelson DE.
Nicotine Tob Res. 2007 May;9(5):525-34. Review.
Preliminary investigation of the advertising and availability of PREPs, the new "safe" tobacco products.
Hickman N, Klonoff EA, Landrine H, Kashima K, Parekh B, Fernandez S, Thomas K, Brouillard C, Zolezzi M, Jensen J, Weslowski Z.
J Behav Med. 2004 Aug;27(4):413-24.
Measures for assessing subjective effects of potential reduced-exposure products.
Hanson K, O'Connor R, Hatsukami D.
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3209-24. Review.
Surveillance of tobacco industry retail marketing activities of reduced harm products.
Slater S, Giovino G, Chaloupka F.
Nicotine Tob Res. 2008 Jan;10(1):187-93.
Potential reduced exposure products (PREPs) in industry trial testimony.
Wayne GF.
Tob Control. 2006 Dec;15 Suppl 4:iv90-7. Review.
Clinical laboratory evaluation of potential reduced exposure products for smokers.
Breland AB, Kleykamp BA, Eissenberg T.
Nicotine Tob Res. 2006 Dec;8(6):727-38.
Retail promotions and perceptions of R.J. Reynolds' novel dissolvable tobacco in a US test market.
Romito LM, Saxton MK, Coan LL, Christen AG.
Harm Reduct J. 2011 May 15;8(1):10.
Smokeless and flavored tobacco products in the U.S.: 2009 Styles survey results.
Regan AK, Dube SR, Arrazola R.
Am J Prev Med. 2012 Jan;42(1):29-36.
Adult tobacco survey - 19 States, 2003-2007.
McClave AK, Whitney N, Thorne SL, Mariolis P, Dube SR, Engstrom M; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2010 Apr 16;59(3):1-75.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on